Kiniksa Pharmaceuticals International, plc (KNSA) has 10 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $299K. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 filed Sept. 1, 2026 | Paolini John F. CHIEF MEDICAL OFFICER | — | +4,299 | — | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Moat Ross CHIEF OPERATING OFFICER | — | +4,278 | — | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Ragosa Mark CHIEF FINANCIAL OFFICER | — | +4,700 | — | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Patel Sanj K CHAIRMAN & CEO | — | +16,174 | — | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Patel Sanj K CHAIRMAN & CEO | — | +16,174 | — | No | |
|
|
||||||
Showing the 5 most recent of 10 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free